BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37402999)

  • 41. Global identification of hnRNP A1 binding sites for SSO-based splicing modulation.
    Bruun GH; Doktor TK; Borch-Jensen J; Masuda A; Krainer AR; Ohno K; Andresen BS
    BMC Biol; 2016 Jul; 14():54. PubMed ID: 27380775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential hnRNP D isoform incorporation may confer plasticity to the ESSV-mediated repressive state across HIV-1 exon 3.
    Hillebrand F; Peter JO; Brillen AL; Otte M; Schaal H; Erkelenz S
    Biochim Biophys Acta Gene Regul Mech; 2017 Feb; 1860(2):205-217. PubMed ID: 27919832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blocking the 5' splice site of exon 4 by a morpholino oligomer triggers APOL1 protein isoform switch.
    Cheatham AM; Davis SE; Khatua AK; Popik W
    Sci Rep; 2018 Jun; 8(1):8739. PubMed ID: 29880816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RBMX suppresses tumorigenicity and progression of bladder cancer by interacting with the hnRNP A1 protein to regulate PKM alternative splicing.
    Yan Q; Zeng P; Zhou X; Zhao X; Chen R; Qiao J; Feng L; Zhu Z; Zhang G; Chen C
    Oncogene; 2021 Apr; 40(15):2635-2650. PubMed ID: 33564070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization.
    Blanchette M; Chabot B
    EMBO J; 1999 Apr; 18(7):1939-52. PubMed ID: 10202157
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HnRNP A1 Suppresses the Odontogenic Differentiation and the Inclusion of RUNX2 Exon 5 of Dental Mesenchymal Cells.
    Zhang Y; Huang J; Yan L; Jia R; Guo J
    Front Biosci (Landmark Ed); 2023 Jul; 28(7):139. PubMed ID: 37525910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer.
    Del Gatto-Konczak F; Olive M; Gesnel MC; Breathnach R
    Mol Cell Biol; 1999 Jan; 19(1):251-60. PubMed ID: 9858549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HnRNP C, YB-1 and hnRNP L coordinately enhance skipping of human MUSK exon 10 to generate a Wnt-insensitive MuSK isoform.
    Nasrin F; Rahman MA; Masuda A; Ohe K; Takeda J; Ohno K
    Sci Rep; 2014 Oct; 4():6841. PubMed ID: 25354590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins.
    Zhu J; Mayeda A; Krainer AR
    Mol Cell; 2001 Dec; 8(6):1351-61. PubMed ID: 11779509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serine/Arginine-Rich Splicing Factor 3 and Heterogeneous Nuclear Ribonucleoprotein A1 Regulate Alternative RNA Splicing and Gene Expression of Human Papillomavirus 18 through Two Functionally Distinguishable cis Elements.
    Ajiro M; Tang S; Doorbar J; Zheng ZM
    J Virol; 2016 Oct; 90(20):9138-52. PubMed ID: 27489271
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SMN2 exon 7 splicing is inhibited by binding of hnRNP A1 to a common ESS motif that spans the 3' splice site.
    Doktor TK; Schroeder LD; Vested A; Palmfeldt J; Andersen HS; Gregersen N; Andresen BS
    Hum Mutat; 2011 Feb; 32(2):220-30. PubMed ID: 21120954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alternatively spliced lysyl oxidase-like 4 isoforms have a pro-metastatic role in cancer.
    Sebban S; Golan-Gerstl R; Karni R; Vaksman O; Davidson B; Reich R
    Clin Exp Metastasis; 2013 Jan; 30(1):103-17. PubMed ID: 22806361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulatory dissection of the CBX5 and hnRNPA1 bi-directional promoter in human breast cancer cells reveals novel transcript variants differentially associated with HP1α down-regulation in metastatic cells.
    Vad-Nielsen J; Jakobsen KR; Daugaard TF; Thomsen R; Brügmann A; Sørensen BS; Nielsen AL
    BMC Cancer; 2016 Jan; 16():32. PubMed ID: 26791953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. hnRNP A1-mediated translational regulation of the G quadruplex-containing RON receptor tyrosine kinase mRNA linked to tumor progression.
    Cammas A; Lacroix-Triki M; Pierredon S; Le Bras M; Iacovoni JS; Teulade-Fichou MP; Favre G; Roché H; Filleron T; Millevoi S; Vagner S
    Oncotarget; 2016 Mar; 7(13):16793-805. PubMed ID: 26930004
    [TBL] [Abstract][Full Text] [Related]  

  • 55. microRNA-18a induces apoptosis in colon cancer cells via the autophagolysosomal degradation of oncogenic heterogeneous nuclear ribonucleoprotein A1.
    Fujiya M; Konishi H; Mohamed Kamel MK; Ueno N; Inaba Y; Moriichi K; Tanabe H; Ikuta K; Ohtake T; Kohgo Y
    Oncogene; 2014 Oct; 33(40):4847-56. PubMed ID: 24166503
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding.
    Marchand V; Méreau A; Jacquenet S; Thomas D; Mougin A; Gattoni R; Stévenin J; Branlant C
    J Mol Biol; 2002 Nov; 323(4):629-52. PubMed ID: 12419255
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Binding of hnRNP H and U2AF65 to respective G-codes and a poly-uridine tract collaborate in the N50-5'ss selection of the REST N exon in H69 cells.
    Ortuño-Pineda C; Galindo-Rosales JM; Calderón-Salinas JV; Villegas-Sepúlveda N; Saucedo-Cárdenas O; De Nova-Ocampo M; Valdés J
    PLoS One; 2012; 7(7):e40315. PubMed ID: 22792276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TDP-43 functions within a network of hnRNP proteins to inhibit the production of a truncated human SORT1 receptor.
    Mohagheghi F; Prudencio M; Stuani C; Cook C; Jansen-West K; Dickson DW; Petrucelli L; Buratti E
    Hum Mol Genet; 2016 Feb; 25(3):534-45. PubMed ID: 26614389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heterogeneous ribonucleoprotein A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathways.
    Matter N; Marx M; Weg-Remers S; Ponta H; Herrlich P; König H
    J Biol Chem; 2000 Nov; 275(45):35353-60. PubMed ID: 10958793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decreased Usage of Specific Scrib Exons Defines a More Malignant Phenotype of Breast Cancer With Worsened Survival.
    Metodieva G; Adoki S; Lausen B; Metodiev MV
    EBioMedicine; 2016 Jun; 8():150-158. PubMed ID: 27428426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.